InspireMD to Present at the LD Micro Virtual Invitational Conference on June 9, 2021

Rhea-AI Summary

InspireMD announced that CEO Marvin Slosman will present a corporate overview at the LD Micro Virtual Invitational Conference from June 8-10, 2021. The presentation is scheduled for June 9 at 11:30 AM ET on Track 3. Investors can register to watch the presentation here. The company aims to set its MicroNet® technology as the standard for carotid stenting, enhancing stroke-free outcomes. InspireMD's common stock trades on Nasdaq under the symbol NSPR.

TEL AVIV, Israel, June 02, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq-CM: NSPR) developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by Carotid Artery Disease (CAD), announced today that Chief Executive Officer Marvin Slosman will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 – 10, 2021.

Mr. Slosman will deliver his corporate presentation on June 9 at 11:30am ET, Track 3.

Investors can register to watch the presentation here.

Investors interested in scheduling a meeting with management should contact assistant@ldmicro.com.

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free, long-term outcomes.

InspireMD’s common stock is quoted on the Nasdaq-CM under the ticker symbol NSPR. The Company’s warrants, NSPR.WS and NSPR.WSB, currently traded on the NYSE: American, have been approved for listing on The Nasdaq Capital Market (“Nasdaq”). Trading is expected to begin on June 8, 2021, under the symbols NSPRW and NSPRZ on the Nasdaq.  

Investor Contacts:
Craig Shore
Chief Financial Officer
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com

CORE IR
investor-relations@inspiremd.com

FAQ

When is Marvin Slosman's presentation at the LD Micro Virtual Invitational Conference?

Marvin Slosman's presentation is scheduled for June 9, 2021, at 11:30 AM ET.

How can I watch InspireMD's presentation?

Investors can register to watch the presentation here.

What is the ticker symbol for InspireMD?

InspireMD's common stock trades on the Nasdaq under the ticker symbol NSPR.

When will InspireMD's warrants begin trading on Nasdaq?

InspireMD's warrants are expected to begin trading on Nasdaq on June 8, 2021, under the symbols NSPRW and NSPRZ.

What technology does InspireMD focus on for carotid stenting?

InspireMD utilizes its proprietary MicroNet® technology to enhance acute results and long-term stroke-free outcomes in carotid stenting.